UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection

Pharmacological reviews, 2008-09, Vol.60 (3), p.358-403

2008

Volltextzugriff (PDF)

Long-term antipsychotic treatments and crossover studies in rats: Differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain

Journal of psychiatric research, 2007-08, Vol.41 (5), p.372-386

2007

Volltextzugriff (PDF)

Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients

Psychiatry research, 2003-12, Vol.121 (2), p.109-122

2003

Volltextzugriff (PDF)

Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain

Journal of psychiatric research, 2003, Vol.37 (1), p.43-51

2003

Volltextzugriff (PDF)

Atypical neuroleptics stimulate neurogenesis in adult rat brain

Journal of neuroscience research, 2002-07, Vol.69 (1), p.72-79

2002

Volltextzugriff (PDF)

Time-dependent cognitive deficits associated with first and second generation antipsychotics: cholinergic dysregulation as a potential mechanism

The Journal of pharmacology and experimental therapeutics, 2007-03, Vol.320 (3), p.961-968

2007

Volltextzugriff (PDF)

Increased truncated TrkB receptor expression and decreased BDNF/TrkB signaling in the frontal cortex of reeler mouse model of schizophrenia

Schizophrenia research, 2008-03, Vol.100 (1), p.325-333

2008

Volltextzugriff (PDF)

Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia

International review of psychiatry (Abingdon, England), 2006-04, Vol.18 (2), p.119-131

2006

Volltextzugriff (PDF)

Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients

Schizophrenia research, 2009-12, Vol.115 (2), p.209-214

2009

Volltextzugriff (PDF)

Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex

Journal of neurochemistry, 2008-11, Vol.107 (4), p.941-951

2008

Volltextzugriff (PDF)

Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol

Neuroscience letters, 2004-02, Vol.356 (2), p.135-139

2004

Volltextzugriff (PDF)

Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology

The international journal of neuropsychopharmacology, 2010-05, Vol.13 (4), p.535-539

2010

Volltextzugriff (PDF)

Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients

Schizophrenia research, 2008-01, Vol.98 (1), p.295-301

2008

Volltextzugriff (PDF)

Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats

The Journal of pharmacology and experimental therapeutics, 2006-08, Vol.318 (2), p.709-724

2006

Volltextzugriff (PDF)

Elevated Plasma Lipid Peroxides at the Onset of Nonaffective Psychosis

Biological psychiatry (1969), 1998-05, Vol.43 (9), p.674-679

1998

Volltextzugriff (PDF)

Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats

Journal of psychiatric research, 2004-09, Vol.38 (5), p.521-529

2004

Volltextzugriff (PDF)

Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus

Schizophrenia research, 2006-02, Vol.82 (1), p.95-106

2006

Volltextzugriff (PDF)

Supplementation with a combination of ω-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia

Schizophrenia research, 2003-08, Vol.62 (3), p.195-204

2003

Volltextzugriff (PDF)

Differential effects of haloperidol and olanzapine on levels of vascular endothelial growth factor and angiogenesis in rat hippocampus

Schizophrenia research, 2006-10, Vol.87 (1), p.48-59

2006

Volltextzugriff (PDF)

Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics

Schizophrenia research, 2002-11, Vol.58 (1), p.1-10

2002

Volltextzugriff (PDF)

Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients

Biological psychiatry (1969), 2003, Vol.53 (1), p.56-64

2003

Volltextzugriff (PDF)

Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia

Progress in neuro-psychopharmacology & biological psychiatry, 2001-04, Vol.25 (3), p.463-493

2001

Volltextzugriff (PDF)

Differential effects of haloperidol and olanzapine on the expression of erythropoietin and its receptor in rat hippocampus and striatum

Journal of neurochemistry, 2006-09, Vol.98 (5), p.1411-1422

2006

Volltextzugriff (PDF)

Erythropoietin Prevents Haloperidol Treatment-Induced Neuronal Apoptosis through Regulation of BDNF

Neuropsychopharmacology (New York, N.Y.), 2008-07, Vol.33 (8), p.1942-1951

2008

Volltextzugriff (PDF)

Free radical pathology and antioxidant defense in schizophrenia: a review

Schizophrenia Research, 1996-03, Vol.19 (1), p.1-17

1996

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(78)
Buchkapitel
(1)

Sprache

Englisch
(79)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(62)
Science & Technology
(62)
Biological And Medical Sciences
(52)
Medical Sciences
(48)
Male
(45)
Psychiatry
(38)
Animals
(37)
Psychology. Psychoanalysis. Psychiatry
(36)
Schizophrenia
(33)
Humans
(31)
Neurosciences & Neurology
(28)
Psychopathology. Psychiatry
(28)
Rats
(28)
Adult And Adolescent Clinical Studies
(26)
Neurosciences
(26)
Psychoses
(26)
Female
(22)
Pharmacology. Drug Treatments
(20)
Adult
(19)
Haloperidol - Pharmacology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection

Long-term antipsychotic treatments and crossover studies in rats: Differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain

Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients

Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain

Atypical neuroleptics stimulate neurogenesis in adult rat brain

Time-dependent cognitive deficits associated with first and second generation antipsychotics: cholinergic dysregulation as a potential mechanism

Increased truncated TrkB receptor expression and decreased BDNF/TrkB signaling in the frontal cortex of reeler mouse model of schizophrenia

Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia

Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients

Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex

Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol

Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology

Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients

Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats

Elevated Plasma Lipid Peroxides at the Onset of Nonaffective Psychosis

Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats

Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus

Supplementation with a combination of ω-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia

Differential effects of haloperidol and olanzapine on levels of vascular endothelial growth factor and angiogenesis in rat hippocampus

Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics

Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients

Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia

Differential effects of haloperidol and olanzapine on the expression of erythropoietin and its receptor in rat hippocampus and striatum

Erythropoietin Prevents Haloperidol Treatment-Induced Neuronal Apoptosis through Regulation of BDNF

Free radical pathology and antioxidant defense in schizophrenia: a review

Suchergebnisse filtern